Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Poster Presentations

Pituitary Clinical

Previous section
Pituitary Basic
Table of contents
Next section
Steroid metabolism + action

ea0029p1361 | Pituitary Clinical

Case series of diabetic ketoacidosis as the first presentation of 860 patients with acromegaly

ea0029p1362 | Pituitary Clinical

Markers of recurrence and long-term morbidity in craniopharyngioma

ea0029p1363 | Pituitary Clinical

Familial isolated pituitary adenoma: review of four families

ea0029p1364 | Pituitary Clinical

A prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease

ea0029p1365 | Pituitary Clinical

IGF1 as a risk factor for insulin resisitance and glucose intolerance in acromegaly

ea0029p1366 | Pituitary Clinical

An insight into the mechanisms underlying the sympathoinhibition of acromegaly

ea0029p1367 | Pituitary Clinical

Aneurysmal subarachnoid haemorrhage is a rare cause of acute glucocorticoid deficiency and long term hypopituitarism

ea0029p1368 | Pituitary Clinical

Hyponatraemia in aneurysmal subarachnoid haemorrhage is due to the syndrome of inappropriate antidiuresis and acute glucocorticoid deficiency

ea0029p1369 | Pituitary Clinical

Pregnancy outcomes following cabergoline treatment in hyperprolactinemic patients: an observational survey study

ea0029p1370 | Pituitary Clinical

Sleep apnea in acromegaly: pathogenetic factors and long-term follow up

ea0029p1371 | Pituitary Clinical

Japan National Survey of metastatic pituitary tumor: preliminary report on 164 cases

ea0029p1372 | Pituitary Clinical

Effects of previous GH excess and current medical treatment for acromegaly on cognition

ea0029p1373 | Pituitary Clinical

Abstract unavailable

ea0029p1374 | Pituitary Clinical

Circulating total and high molecular weight adiponectin levels are lower in adult GH deficient subjects

ea0029p1375 | Pituitary Clinical

Quality of life and mood disturbances in patients with acromegaly followed-up in a single center

ea0029p1376 | Pituitary Clinical

Low total cortisol correlates closely with low free cortisol in traumatic brain injury and predicts mortality and long term hypopituitarism

ea0029p1377 | Pituitary Clinical

Array-comparative genomic hybridization in congenital morphological alteration of the pituitary gland

ea0029p1378 | Pituitary Clinical

Low IGF1 levels are associated with a lower prevalence and incidence of anxiety disorders in primary care patients (DETECT cohort) and the general population (SHIP cohort)

ea0029p1379 | Pituitary Clinical

Epidemiology, histophatological characteristics and clinical manifestations of aggressive pituitary tumors, evaluated on the basis of KI-67 immunostaining: a single center experiense

ea0029p1380 | Pituitary Clinical

Congenital hypopituitarism with ectopic posterior pituitary and pulmonic stenosis: hormonal and radiologic followup into adulthood

ea0029p1381 | Pituitary Clinical

Childhood onset craniopharyngiomas have normal selfrating quality of life but impaired neurocognitive function in adult life

ea0029p1382 | Pituitary Clinical

Orexin A concentration is reduced in acromegaly, regardless activity of the disease

ea0029p1383 | Pituitary Clinical

No evidence for detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

ea0029p1384 | Pituitary Clinical

Prevalence and incidence of pituitary adenomas; a population based study in Malta

ea0029p1385 | Pituitary Clinical

Markers of disease activity correlate with cephalometric parameters in acromegalic patients

ea0029p1386 | Pituitary Clinical

Management of giant cystic invasive prolactinoma-the role of medical therapy revisited

ea0029p1387 | Pituitary Clinical

Surveillance study on the prevalence of manifestations, complications and illness associated to acromegaly

ea0029p1388 | Pituitary Clinical

Diabetes insipidus could be the initial sign of primary hypophysitis

ea0029p1389 | Pituitary Clinical

Evaluation of metabolic parameters in patients with craniopharyngiomas using visceral adiposity index

ea0029p1390 | Pituitary Clinical

Oxidative stress and reduced anti-oxidative status, along with endothelial dysfunction in acromegaly

ea0029p1391 | Pituitary Clinical

Evaluation of clinical presentation, treatment approach and outcome of a cohort of patients with acromegaly: a single centre experience

ea0029p1392 | Pituitary Clinical

Permanent panhypopituitarism is a rare complication of acute bacterial sinusitis

ea0029p1393 | Pituitary Clinical

Carboplatin is a novel cause of the syndrome of inappropriate antidiuresis

ea0029p1394 | Pituitary Clinical

Evaluation of ejaculatory function in acromegalic men: preliminary study

ea0029p1395 | Pituitary Clinical

Evaluation of male sexual function in active acromegalic patients and after disease remission: preliminary study

ea0029p1396 | Pituitary Clinical

The clinical outcome of pituitary adenomas in the cavernous sinus

ea0029p1397 | Pituitary Clinical

Outcome of transsphenoidal surgery for Cushing’s disease dependent on tumor size: a single center experience

ea0029p1398 | Pituitary Clinical

Effects of medical therapy of acromegaly on glucose metabolism

ea0029p1399 | Pituitary Clinical

Insulin resistance and the effect of treatment on insulin resistance in patients with prolactinoma

ea0029p1400 | Pituitary Clinical

Effects on GH/IGF1 hypersecretion and tumor size of long-acting somatostatin analogue (Sandostatin LAR) in patients with untreated acromegaly and in previously treated with surgery and/or radiotherapy

ea0029p1401 | Pituitary Clinical

Management of hyponatremia in the hospital: interim results from a prospective, observational, multi-center, global registry

ea0029p1402 | Pituitary Clinical

Cardiac magnetic resonance imaging detects myocardial fibrosis in patients with active acromegaly

ea0029p1403 | Pituitary Clinical

Pregnancies in a large cohort of patients on growth hormone replacement therapy

ea0029p1404 | Pituitary Clinical

Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study

ea0029p1405 | Pituitary Clinical

Long-term use of pasireotide in Cushing’s disease: 24-month safety results from a randomized phase III study

ea0029p1406 | Pituitary Clinical

Pasireotide treatment is associated with improvements in hypertension: 12-month results from a large phase III study in Cushing’s disease

ea0029p1407 | Pituitary Clinical

GH Secretion response to triple secretagogue stimulus (ghrh, ghrelin and arginine) is gender and BMI dependent in healthy postmenopausal women and older men

ea0029p1408 | Pituitary Clinical

Pasireotide treatment is associated with clinically meaningful improvements in health-related quality of life in Cushing’s disease: results from a large, randomized, double-blind phase III trial

ea0029p1409 | Pituitary Clinical

Increased risk of hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors with the use of concurrent chemo-irradiation

ea0029p1410 | Pituitary Clinical

Long-term pasireotide use leads to improvements in the biochemical parameters of Cushing’s disease: 24-month results from a randomized phase III study

ea0029p1411 | Pituitary Clinical

Hyperprolactinemic patients are prone to increased protein oxidation: a risk for low grade inflammation?

ea0029p1412 | Pituitary Clinical

Fifteen years of GH replacement improves body composition and metabolic parameters

ea0029p1413 | Pituitary Clinical

Incidence of hypogonadism and evaluation of its impact on cardiovascular risk factors and quality of life in acromegalic patients

ea0029p1414 | Pituitary Clinical

GH secretory function is well preserved in surgically cured acromegalics

ea0029p1415 | Pituitary Clinical

The effect of GH replacement therapy on exercise capacity, fat mass, ectopic lipids intramyocellular and intrahepatocellular lipids and insulin resistance in hypopituitary patients with GH deficiency

ea0029p1416 | Pituitary Clinical

Prevalence of central adrenal insufficiency during lifespan in Prader–Willi syndrome

ea0029p1417 | Pituitary Clinical

Limited effects of temozolomide monotherapy on aggressive pituitary tumors. -Based on our own experiences of three cases-

ea0029p1418 | Pituitary Clinical

The impact of long-acting somatostatin analogs treatment on glucose tolerance and insulin resistance in acromegaly.

ea0029p1419 | Pituitary Clinical

Immunohistochemical detection of sstr2 and 5 ligand binding domains in 110 pituitary tumors

ea0029p1420 | Pituitary Clinical

Symptomatic hypotonic hyponatraemia after endoscopic transsphenoidal surgery: results from two large series

ea0029p1421 | Pituitary Clinical

Audit of pituitary dysfunction after traumatic brain injury: caution in interpretation of glucagon stimulation test in diagnosis of GH and ACTH deficiency.

ea0029p1422 | Pituitary Clinical

Body composition has a higher impact on peak GH during the pyridostigmine–GHRH test than the insulin tolerance test in healthy individuals

ea0029p1423 | Pituitary Clinical

Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study

ea0029p1424 | Pituitary Clinical

Cavernous Sinus Sampling (CSS) - a specific method for localization of minute ACTH secreting adenomas in Cushing Disease (CD)

ea0029p1425 | Pituitary Clinical

Effects of medical treatment on proliferation parameters MIB-1 and topoisomerase-IIα in GH secreting pituitary adenomas

ea0029p1426 | Pituitary Clinical

Comprasion of cycline D1 gene (Ccnd1) polymorphism in invasive and non-invasive prolactinomas

ea0029p1427 | Pituitary Clinical

Control of GH and IGF1 in acromegaly in the UK: responses to medical treatment

ea0029p1428 | Pituitary Clinical

Low tumoral mRNA IGF2 might balance the mechanism of tumorigenesis in GH-secreting adenomas

ea0029p1429 | Pituitary Clinical

Synergistic effects of combined stimulation with CRH+ghrelin on ACTH and cortisol responses in patients with Cushing’s disease: a pilot study

ea0029p1430 | Pituitary Clinical

Bone turnover in patients with active acromegaly in relation to glucose metabolism

ea0029p1431 | Pituitary Clinical

Relationship between gsp mutations and clinico-pathological features in GH producing pituitary adenomas

ea0029p1432 | Pituitary Clinical

Decreased IGF1 levels and GH-resistant hepatic state to estrogens during the first trimester of pregnancy in non-acromegalic women

ea0029p1433 | Pituitary Clinical

Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas

ea0029p1434 | Pituitary Clinical

Mortality rates in childhood and adult onset GH deficient patients enrolled in the Global Hypopituitary Control and Complications Study (HypoCCS)

ea0029p1435 | Pituitary Clinical

Experience in the use of tolvaptan in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH)

ea0029p1436 | Pituitary Clinical

Blast concussion is associated with high frequency of pituitary dysfunction

ea0029p1437 | Pituitary Clinical

Efficacy of transsphenoidal surgery for Cushing’s disease: the role of combined dexamethasone desmopressin test

ea0029p1438 | Pituitary Clinical

Improved renal function after five years of GH therapy in GH deficient (GHD) adult survivors of childhood leukaemia

ea0029p1439 | Pituitary Clinical

Thyrotropin-secreting pituitary adenomas: experience of a single centre

ea0029p1440 | Pituitary Clinical

Detection of somatostatin receptors in aggressive non-functioning pituitary adenomas and effects of somatostatin analogs therapy in these tumors

ea0029p1441 | Pituitary Clinical

Effect of a modulation of somatostatin release on TSH secretion in healthy volunteers

ea0029p1442 | Pituitary Clinical

Are “in silico” predictions reliable regarding splice-site mutations? – Studies in the aryl hydrocarbon receptor-interacting protein (AIP)

ea0029p1443 | Pituitary Clinical

Effectiveness of cyberknife in the management of pituitary adenomas and craniopharyngiomas

ea0029p1444 | Pituitary Clinical

Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

ea0029p1445 | Pituitary Clinical

Pituitary tumor apoplexy: overview of 14 cases diagnosed during the last 12 years at a central hospital

ea0029p1446 | Pituitary Clinical

Copeptin is not associated with menstrual cycle hormones

ea0029p1447 | Pituitary Clinical

Acylated ghrelin as provocative test for the diagnosis of gh deficiency in adults

ea0029p1448 | Pituitary Clinical

National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden

ea0029p1449 | Pituitary Clinical

High mean platelet volume and lipid abnormalities in prolactinoma patients without insulin resistance

ea0029p1450 | Pituitary Clinical

Asymptomatic nonfunctioning pituitary macroadenomas take advantage of surgery

ea0029p1451 | Pituitary Clinical

Mortality and survival in a large series of adult patients with hypopituitarism followed for 10 years

ea0029p1452 | Pituitary Clinical

Gastric and colonic pathology at patients with active acromegaly

ea0029p1453 | Pituitary Clinical

Pituitary dysfunction in adult patients after cranial radiotherapy for non-pituitary tumors: a long-term follow-up study

ea0029p1454 | Pituitary Clinical

The treatment of results of endoscopic transsphenoidal surgery for GH-secreting pituitary adenomas

ea0029p1455 | Pituitary Clinical

Glucose metabolism in children with GH deficiency before and after GH therapy

ea0029p1456 | Pituitary Clinical

Endocrine disturbances and quality of life in adult patients after multimodal treatment for brain tumors or leukemia

ea0029p1457 | Pituitary Clinical

Anterior pituitary autoantibodies in patients with diabetes mellitus

ea0029p1458 | Pituitary Clinical

Pitfalls in Cushing’s disease: report of an ectopic ACTH-producing pituitary adenoma in the sphenoid sinus

ea0029p1459 | Pituitary Clinical

The effect of Ki67 index on tumor behavior in proloctanimas

ea0029p1460 | Pituitary Clinical

Cyclin D1 gene exon 4/intron 4 region A / G polymorphism and allele ratios in patients with prolactinoma

ea0029p1461 | Pituitary Clinical

Cancer detection in long-term follow-up of patients with acromegaly

ea0029p1462 | Pituitary Clinical

Study on IGF(CA)19 gene polymorphism in adults with GH deficiency

ea0029p1463 | Pituitary Clinical

META-analysis on the effects of octreotide on tumor mass in acromegaly

ea0029p1464 | Pituitary Clinical

Parasellar masses: experience in 47 patients

ea0029p1465 | Pituitary Clinical

Colonic neoplasms in acromegaly: are there serum risk factors?

ea0029p1466 | Pituitary Clinical

No long-term weight reduction after gastric banding in obese patients with craniopharyngioma involving hypothalamic structures: experiences from KRANIOPHARYNGEOM 2000

ea0029p1467 | Pituitary Clinical

Predictors of the acromegaly-associated mortality in the last decade

ea0029p1468 | Pituitary Clinical

Endoscopic transsphenoidal surgery as the therapy of choice for acromegaly: a 13-year experience in a single centre

ea0029p1469 | Pituitary Clinical

MALE macroprolactinomas: response to medical treatement

ea0029p1470 | Pituitary Clinical

Evaluation of pituitary gland with magnetic resonance imaging in hypogonadic patients

ea0029p1471 | Pituitary Clinical

Is acromegaly associated with irritable bowel syndrome?

ea0029p1472 | Pituitary Clinical

Acromegaly, does tumor size matters?

ea0029p1473 | Pituitary Clinical

Clinical and histological characteristics of giant GH producing pituitary adenomas

ea0029p1474 | Pituitary Clinical

Long-term outcomes after sterotactic radiosurgery for non-functioning pituitary adenomas

ea0029p1475 | Pituitary Clinical

Long-term outcomes after sterotactic radiosurgery for functioning pituitary adenomas

ea0029p1476 | Pituitary Clinical

Comparison of immunoassay and mass spectrometry measurement of cortisol during ACTH1--24 stimulation tests

ea0029p1477 | Pituitary Clinical

Cushing’s disease: prospective assessment of factors influencing the efficacy of transsphenoidal surgery

ea0029p1478 | Pituitary Clinical

The results of surgical treatment on prolactinomas in females of child bearing ages

ea0029p1479 | Pituitary Clinical

Treatment outcomes in prolactinomas with and without cavernous sinus invasion

ea0029p1480 | Pituitary Clinical

Change in somatostatinergic tone of acromegalic patients according to the size of GH-producing pituitary tumors

ea0029p1481 | Pituitary Clinical

Two cases of sever congenital central hypothyroidism with TSH and prolactin deficiency-possible new syndrome

ea0029p1482 | Pituitary Clinical

Treatment response and comorbilities in acromegalic patients

ea0029p1483 | Pituitary Clinical

Reproductive function in acromegalic women: a one-center experience

ea0029p1484 | Pituitary Clinical

Evaluation of bone mass and fracture in patients with prolactinoma

ea0029p1485 | Pituitary Clinical

Prolactin levels are correlated with tumor size and invasiveness in prolactinomas

ea0029p1486 | Pituitary Clinical

Is every joint symptom related to acromegaly?

ea0029p1487 | Pituitary Clinical

Acromegaly and pregnancy: case reports

ea0029p1488 | Pituitary Clinical

Pegvisomant and cabergoline combination therapy in acromegaly

ea0029p1489 | Pituitary Clinical

Influence of the family environment during the early years in life in the vulnerability to the development of pituitary adenomas

ea0029p1490 | Pituitary Clinical

Hyperprolactinemia in polycystic ovary syndrome- diagnostic and therapeutic approach

ea0029p1491 | Pituitary Clinical

Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma

ea0029p1492 | Pituitary Clinical

Mood Disorders and Quality of Life in Patients with Acromegaly after Pituitary Adenomas

ea0029p1493 | Pituitary Clinical

Although dentists are frequently visited by acromegaly patients they do not diagnose the disease

ea0029p1494 | Pituitary Clinical

The long term recurrence rates of cushing’s disease in turkish patients after transsphenodal surgery: a single-center experience

ea0029p1495 | Pituitary Clinical

Xanthoma disseminatum with cutaneous and pituitary stalk involvement

ea0029p1496 | Pituitary Clinical

Acromegaly and charles bonnet syndrome

ea0029p1497 | Pituitary Clinical

Planning for the future: preparing the endocrine specialist nurse of tomorrow

ea0029p1498 | Pituitary Clinical

Changes in body composition in patients with acromegaly

ea0029p1499 | Pituitary Clinical

Complications of pure endoscopic transsphenoidal surgery for pituitary adenoma

ea0029p1500 | Pituitary Clinical

A case of nephrotic syndrome hidden by cushing’s disease

ea0029p1501 | Pituitary Clinical

Preliminary report of hypoglycemic response in obese metabolic syndrome males treated with metformin after weight loss intervention

ea0029p1502 | Pituitary Clinical

A difficult case of hyponatraemia in a neurosurgical patient

ea0029p1503 | Pituitary Clinical

Invasive and giant pituitary adenomas in the elderly

ea0029p1504 | Pituitary Clinical

Hyperprolactinemia: prolactinoma or pregnancy?

ea0029p1505 | Pituitary Clinical

DHEAS: a new marker in Cushing’s disease? Preliminary results of 32 patients

ea0029p1506 | Pituitary Clinical

Clinical experience with acromegalic patients who have macroadenomas and long term follow-up results

ea0029p1507 | Pituitary Clinical

Glucose metabolism and lipid disturbances in acromegalic patients before and during treatment with long-acting somatostatin analogues

ea0029p1508 | Pituitary Clinical

The therapy with cabergoline evaluation of men with macroprolactinoma

ea0029p1509 | Pituitary Clinical

Efficacy of testerone 2% gel replacement therapy on erectile function, muscle strenght and general wellbeing in men affected by normo-hypogonadotropic hypogonadism

ea0029p1510 | Pituitary Clinical

Follow up of pituitary incidentaloma: a study in 140 patients

ea0029p1511 | Pituitary Clinical

Macroprolactin levels in healthy blood donors

ea0029p1512 | Pituitary Clinical

Sleep apnoea syndrome in acromegaly

ea0029p1513 | Pituitary Clinical

Therapeutic trends, long-term outcome and efficacy of different treatment modalities in acromegaly: a single center registry covering a 40 year period

ea0029p1514 | Pituitary Clinical

Prevalence of the metabolic syndrome in patients with adult growth hormone deficiency before GH treatment

ea0029p1515 | Pituitary Clinical

Familial central diabetes insipidus with extremely high water intake

ea0029p1516 | Pituitary Clinical

Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients

ea0029p1517 | Pituitary Clinical

Isolated diabetes insipidus happened during premenopause solution ten years after

ea0029p1518 | Pituitary Clinical

Metaplastic Rathke’s cyst leading to hypopituitarism

ea0029p1519 | Pituitary Clinical

Pituitary macroadenomas: benefit from early GH substitution after surgery

ea0029p1520 | Pituitary Clinical

Pituitary insufficiency in the acute phase of traumatic brain injury or subarachnoid hemorrhage, prevalence and predictive factors: a prospective, population based study

ea0029p1521 | Pituitary Clinical

Difference of response to TRH (thyrotropin releasing hormone) stimulation according to octreotide response and the size of GH-producing pituitary adenomas

ea0029p1522 | Pituitary Clinical

Ovarian hyperstimulation syndrome due to a functioning gonadotroph adenoma

ea0029p1523 | Pituitary Clinical

GH deficiency after treatment of medulloblastoma and thyroid cancer: is this the case for GH therapy?

ea0029p1524 | Pituitary Clinical

Thyrotropinoma. A rare case report of hyperthyroidism

ea0029p1525 | Pituitary Clinical

The dermatologic evaluation of acromegaly patients

ea0029p1526 | Pituitary Clinical

Growth hormone effects on lipid profile in patients with acromegaly

ea0029p1527 | Pituitary Clinical

Pituitary lesions: Pituitary adenomas and what else?

ea0029p1528 | Pituitary Clinical

Progressive combined pituitary hormone deficiency produced by Prop1 gene mutation

ea0029p1529 | Pituitary Clinical

Neurohypohysis tumors: about two cases

ea0029p1530 | Pituitary Clinical

Hypersomatotropism and glucose metabolism disorders

ea0029p1531 | Pituitary Clinical

Hyperprolactinemia: etiology, diagnosis and therapeutic aspects

ea0029p1532 | Pituitary Clinical

Clinical, biological and radiological confrontation in Cushing disease

ea0029p1533 | Pituitary Clinical

Characteristics of giant and huge male prolactinomas

ea0029p1534 | Pituitary Clinical

A case of acromegaly in the presence of coincidental liver cirrhosis

ea0029p1535 | Pituitary Clinical

Adiponectin and cardiac structure in acromegaly

ea0029p1536 | Pituitary Clinical

A case of acromegaly diagnosed with diabetic ketoacidosis as a primary manifestation

ea0029p1537 | Pituitary Clinical

The role of long acting somatostatin analogues on glucose homeostasis in acromegaly

ea0029p1538 | Pituitary Clinical

Clinical features of inferior and lateral invasive expansion of GH-producing adenoma

ea0029p1539 | Pituitary Clinical

Predictive value of acute octreotide supression test in newly diagnosed acromegaly

ea0029p1540 | Pituitary Clinical

An unusual plurihormonal pituitary adenoma

ea0029p1541 | Pituitary Clinical

Results of pegvisomant therapy in patients with acromegaly

ea0029p1542 | Pituitary Clinical

Panhypopituitarism and central diabetes insipidus: a case report

ea0029p1542.1 | Pituitary Clinical

Evaluation of the efficacy and safety of pasireotide LAR in patients with mild-to-moderate cushing’s disease: a randomized, double-blind, multicenter, phase III study design

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more